As expected, U87MG glioma cells expressing the IDH1-R132H mutant and patient-derived xenografts from IDH1 mutant GBM both showed lower cellular NADPH levels and a decreased [NADPH]/[NADP+] ratio [102,103]. The gene discussed is IDH1; the disease is glioblastoma.